[1] Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: A review [J]. Med Sci Monit, 2019, 25: 3537-3541. [2] Goetze OT, Al-Batran SE, Chevallay M, et al. Multimodal treatment in locally advanced gastric cancer [J]. Updates Surg, 2018, 70(2): 173-179. [3] 赵翔宇, 何振宇, 宰守峰. 人参皂苷Rg5对胃癌细胞周期和侵袭的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(1): 51-55. [4] Londhe VP, Gavasane AT, Nipate SS, et al. Role of garlic (allium sativum) in various diseases: An overview [J]. J Pharm Res Opin, 2011, 1: 129-134. [5] Iman EW, Alaa MRA. Combined activity of garlic and nitrofurantoin against escherichia coli and enterococcus species recovered from urinary tract infections [J]. Afr J Microbiol Res, 2014, 8(7): 644-651. [6] Lv Y, So KF, Wong NK, et al. Anti-cancer activities of S-allylmercaptocysteine from aged garlic [J]. Chin J Nat Med, 2019, 17(1): 43-49. [7] Siyo V, Schäfer G, Hunter R, et al. The cytotoxicity of the ajoene analogue bisPMB in WHCO1 oesophageal cancer cells is mediated by CHOP/GADD153 [J]. Molecules, 2017, 22(6): 892-910. [8]Kaschula CH, Hunter R, Cotton J, et al. The garlic compound ajoene targets protein folding in the endoplasmic reticulum of cancer cells [J]. Mol Carcinog, 2016, 55(8): 1213-1228. [9]Li H, Jeong JH, Kwon SW, et al. Z-Ajoene inhibits growth of colon cancer by promotion of CK1α dependent β-catenin phosphorylation [J]. Molecules, 2020, 25(3): 703-710. [10] Wang Y, Sun Z, Chen S, et al. ROS-mediated activation of JNK/p38 contributes partially to the pro-apoptotic effect of ajoene on cells of lung adenocarcinoma [J]. Tumour Biol, 2016, 37(3): 3727-3738. [11] Hu M, Zhu S, Xiong S, et al. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review) [J]. Oncol Rep, 2019, 41(3): 1439-1454. [12] Su CC. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway [J]. Int J Mol Med, 2018, 41(4): 2389-2396. [13] Su CC. Tanshinone IIA can inhibit MiaPaCa2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways [J]. Oncol Rep, 2018, 40(5): 3102-3111. [14] Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance [J]. Semin Cancer Biol, 2019, 59: 147-160. [15] Barra F, Evangelisti G, Ferro Desideri L, et al. Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer [J]. Expert Opin Investig Drugs, 2019, 28(2): 131-142. [16] Kumar D, Shankar S, Srivastava R. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via pi3k /akt/mtor signaling pathway [J]. Cancer Lett, 2014, 343(2): 179-189. [17] Hales E, Taub J, Matherly L. New insights into notch1 regulation of the pi3k-akt-mtor1 signaling axis: Targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia [J]. Cell Signal, 2014, 26(1): 149-161. [18] Mirakhor Samani S, Ezazi Bojnordi T, Zarghampour M, et al. Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study [J]. J Obstet Gynaecol, 2018, 38(7): 999-1004. [19] Gogada R, Prabhu V, Amadori M, et al. Resveratrol induces p53-independent, x-linked inhibitor of apoptosis protein (xiap)-mediated bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation [J]. J Biol Chem, 2011, 286(33): 28749-28760. [20] 奉水东, 伍 迪, 杨丝丝, 等. 槟榔碱对人乳腺癌MCF-7细胞增殖和凋亡的影响[J]. 中国应用生理学杂志, 2016, 32(4): 370-372. [21] Jiang Y, Fang B, Xu B, et al. The RAS-PI3K-AKT-NF-κB pathway transcriptionally regulates the expression of BCL2 family and IAP family genes and inhibits apoptosis in fibrous epulis [J]. J Clin Lab Anal, 2020, 34(3): e23102-e23108. |